Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
BLFS Stock — BioLife Solutions, Inc.
Renamed. The figures below are frozen at this symbol's final trading day. Now trading as RGEN.
BioLife Solutions, Inc. (BLFS)
Updated October 5, 2026.
BioLife Solutions develops and manufactures specialized biopreservation media, bioproduction products, and automated processing equipment for the cell and gene therapy industry, serving research and commercial manufacturing customers globally. The company does not currently have an established regular distribution schedule. This equity security may appeal to investors seeking exposure to the cell and gene therapy sector without an expectation of dividend income. BioLife Solutions was acquired by Repligen on October 6, 2026, with each share converted into $11.25 in cash plus 0.1442 Repligen shares, and its stock was delisted from Nasdaq; see RGEN for the acquirer.
BLFS key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 11/22/1989
- Distribution frequency
- None
- Last close
- $38.61 (stale; as of 2026-10-05)
- Market cap
- $1,888,929,920
- Average volume
- 1,164,074
- Beta
- 1.824
- Payout ratio
- 0.0%
- P/E ratio
- 39.00
- Forward P/E
- 117.00
- EPS
- $0.99
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.